BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 7489990)

  • 1. Hepatoma cell-specific expression of a retrovirally transferred gene is achieved by alpha-fetoprotein but not insulinlike growth factor II regulatory sequences.
    Arbuthnot P; Bralet MP; Thomassin H; Danan JL; Bréchot C; Ferry N
    Hepatology; 1995 Dec; 22(6):1788-96. PubMed ID: 7489990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene therapy for alpha-fetoprotein-producing human hepatoma cells by adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene.
    Kanai F; Shiratori Y; Yoshida Y; Wakimoto H; Hamada H; Kanegae Y; Saito I; Nakabayashi H; Tamaoki T; Tanaka T; Lan KH; Kato N; Shiina S; Omata M
    Hepatology; 1996 Jun; 23(6):1359-68. PubMed ID: 8675152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene therapy for hepatoma cells using a retrovirus vector carrying herpes simplex virus thymidine kinase gene under the control of human alpha-fetoprotein gene promoter.
    Ido A; Nakata K; Kato Y; Nakao K; Murata K; Fujita M; Ishii N; Tamaoki T; Shiku H; Nagataki S
    Cancer Res; 1995 Jul; 55(14):3105-9. PubMed ID: 7541712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene therapy targeting for hepatocellular carcinoma: selective and enhanced suicide gene expression regulated by a hypoxia-inducible enhancer linked to a human alpha-fetoprotein promoter.
    Ido A; Uto H; Moriuchi A; Nagata K; Onaga Y; Onaga M; Hori T; Hirono S; Hayashi K; Tamaoki T; Tsubouchi H
    Cancer Res; 2001 Apr; 61(7):3016-21. PubMed ID: 11306481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo hepatoma cell-specific expression of a gene transferred with an adenoviral vector.
    Arbuthnot PB; Bralet MP; Le Jossic C; Dedieu JF; Perricaudet M; Bréchot C; Ferry N
    Hum Gene Ther; 1996 Aug; 7(13):1503-14. PubMed ID: 8864751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulatory regions of growth-related genes can activate an exogenous gene of the alpha-fetoprotein promoter to a comparable degree in human hepatocellular carcinoma cells.
    Tomizawa M; Saisho H; Tagawa M
    Anticancer Res; 2003; 23(4):3273-7. PubMed ID: 12926063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of alpha-fetoprotein and albumin genes in human hepatocellular carcinomas: limitations in the application of the genes for targeting human hepatocellular carcinoma in gene therapy.
    Ohguchi S; Nakatsukasa H; Higashi T; Ashida K; Nouso K; Ishizaki M; Hino N; Kobayashi Y; Uematsu S; Tsuji T
    Hepatology; 1998 Feb; 27(2):599-607. PubMed ID: 9462663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An advanced strategy of enhanced specific gene expression for hepatocellular carcinoma.
    Takikawa H; Mafune K; Hamada H; Nettelbeck DM; Müller R; Makuuchi M; Kaminishi M
    Int J Oncol; 2003 May; 22(5):1051-6. PubMed ID: 12684671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retrovirus-mediated gene therapy for hepatocellular carcinoma with reversely oriented therapeutic gene expression regulated by alpha-fetoprotein enhancer/promoter.
    Ishikawa H; Nakata K; Mawatari F; Ueki T; Tsuruta S; Ido A; Nakao K; Kato Y; Ishii N; Eguchi K
    Biochem Biophys Res Commun; 2001 Oct; 287(4):1034-40. PubMed ID: 11573968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AFP promoter enhancer increased specific expression of the human sodium iodide symporter (hNIS) for targeted radioiodine therapy of hepatocellular carcinoma.
    Ma XJ; Huang R; Kuang AR
    Cancer Invest; 2009 Jul; 27(6):673-81. PubMed ID: 19241193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utilization of variant-type of human alpha-fetoprotein promoter in gene therapy targeting for hepatocellular carcinoma.
    Ishikawa H; Nakata K; Mawatari F; Ueki T; Tsuruta S; Ido A; Nakao K; Kato Y; Ishii N; Eguchi K
    Gene Ther; 1999 Apr; 6(4):465-70. PubMed ID: 10476206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrovirus-mediated gene therapy for hepatocellular carcinoma: selective and enhanced suicide gene expression regulated by human alpha-fetoprotein enhancer directly linked to its promoter.
    Mawatari F; Tsuruta S; Ido A; Ueki T; Nakao K; Kato Y; Tamaoki T; Ishii N; Nakata K
    Cancer Gene Ther; 1998; 5(5):301-6. PubMed ID: 9824049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Construction of a hepatoma-targeting vector of adeno-associated virus containing human alpha-fetoprotein promoter and wild p53 gene in gene therapy of liver cancer].
    Cheng J; Leng X; Peng J
    Zhonghua Yi Xue Za Zhi; 2000 Jun; 80(6):461-3. PubMed ID: 11798803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Retroviral-mediated transcriptional regulatory elements of alpha-fetoprotein gene directed specific expression of interleukin-2 in murine hepatoma].
    Ma Q; Wu Y; Yu L; Zhang Y
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1998 Oct; 20(5):334-8. PubMed ID: 11717988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The targeted expression of interleukin-2 in human hepatocellular carcinoma cells.
    He P; Tang ZY; Ye SL; Liu BB; Liu YK
    J Exp Clin Cancer Res; 2000 Jun; 19(2):183-7. PubMed ID: 10965816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A hepatocellular carcinoma-specific adenovirus variant, CV890, eliminates distant human liver tumors in combination with doxorubicin.
    Li Y; Yu DC; Chen Y; Amin P; Zhang H; Nguyen N; Henderson DR
    Cancer Res; 2001 Sep; 61(17):6428-36. PubMed ID: 11522637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of an oncodevelopmental gene product (alpha-fetoprotein) during fetal development and adult oncogenesis.
    Sell S; Becker FF; Leffert HL; Watabe L
    Cancer Res; 1976 Nov; 36(11 Pt. 2):4239-49. PubMed ID: 61804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Construction of a plasmid vector of fused protein genes driven by human insulin-like growth factor II P3 promoter].
    Zhou HK; Yang DH; Tang SH; Huang W; Lu XH
    Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(2):106-10. PubMed ID: 16620715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Construction and study of replication-defective adenovirus targeting hepatocarcinoma].
    Xu DY; Du ZY; Wang Y; Chen HH; Xu YJ; Lu YL
    Ai Zheng; 2006 Jul; 25(7):798-804. PubMed ID: 16831267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting gene therapy for hepatocarcinoma cells with the E. coli purine nucleoside phosphorylase suicide gene system directed by a chimeric alpha-fetoprotein promoter.
    Cai X; Zhou J; Chang Y; Sun X; Li P; Lin J
    Cancer Lett; 2008 Jun; 264(1):71-82. PubMed ID: 18407409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.